Rasmus Ehren

592 total citations
22 papers, 234 citations indexed

About

Rasmus Ehren is a scholar working on Nephrology, Pathology and Forensic Medicine and Transplantation. According to data from OpenAlex, Rasmus Ehren has authored 22 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 6 papers in Pathology and Forensic Medicine and 6 papers in Transplantation. Recurrent topics in Rasmus Ehren's work include Renal Diseases and Glomerulopathies (13 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Autoimmune Bullous Skin Diseases (5 papers). Rasmus Ehren is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Autoimmune Bullous Skin Diseases (5 papers). Rasmus Ehren collaborates with scholars based in Germany, Italy and Netherlands. Rasmus Ehren's co-authors include Lutz T. Weber, Sandra Habbig, Carsten Müller, Christina Taylan, Jörg Dötsch, Max C. Liebau, Michaela Geßner, Marcus R. Benz, Orsolya Cseprekál and Jutta Gellermann and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Nephrology Dialysis Transplantation.

In The Last Decade

Rasmus Ehren

21 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rasmus Ehren Germany 12 169 59 40 39 38 22 234
R. Nair United States 6 137 0.8× 30 0.5× 32 0.8× 27 0.7× 37 1.0× 8 216
Pantelitsa Kalliakmani Greece 9 109 0.6× 42 0.7× 53 1.3× 14 0.4× 22 0.6× 22 216
F. Egidi United States 10 81 0.5× 134 2.3× 24 0.6× 38 1.0× 24 0.6× 23 292
Eric S. Campenot United States 7 120 0.7× 91 1.5× 89 2.2× 29 0.7× 27 0.7× 10 268
Biswanath Basu India 10 233 1.4× 10 0.2× 54 1.4× 50 1.3× 80 2.1× 26 321
John O’Regan Ireland 6 177 1.0× 96 1.6× 49 1.2× 131 3.4× 16 0.4× 9 298
Laila‐Yasmin Mani Switzerland 4 136 0.8× 9 0.2× 77 1.9× 49 1.3× 76 2.0× 10 293
J. Floege Germany 8 129 0.8× 11 0.2× 33 0.8× 29 0.7× 23 0.6× 11 238
Charlotte Colosio France 9 51 0.3× 108 1.8× 31 0.8× 33 0.8× 23 0.6× 18 254
Prince Mohan United States 10 71 0.4× 98 1.7× 38 0.9× 16 0.4× 9 0.2× 32 254

Countries citing papers authored by Rasmus Ehren

Since Specialization
Citations

This map shows the geographic impact of Rasmus Ehren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rasmus Ehren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rasmus Ehren more than expected).

Fields of papers citing papers by Rasmus Ehren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rasmus Ehren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rasmus Ehren. The network helps show where Rasmus Ehren may publish in the future.

Co-authorship network of co-authors of Rasmus Ehren

This figure shows the co-authorship network connecting the top 25 collaborators of Rasmus Ehren. A scholar is included among the top collaborators of Rasmus Ehren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rasmus Ehren. Rasmus Ehren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, Lutz T., Anna Greta Barbe, Rasmus Ehren, et al.. (2024). Intensive oral prophylaxis does not alter the tongue microbiome in young patients with chronic kidney disease: longitudinal, randomized, controlled study. Frontiers in Immunology. 15. 1430655–1430655. 1 indexed citations
2.
Kühne, Lucas, Rasmus Ehren, Lutz T. Weber, et al.. (2023). Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS. Scientific Reports. 13(1). 6980–6980. 5 indexed citations
3.
Ehren, Rasmus, Sandra Habbig, Kai Krupka, et al.. (2022). Prevalence and potential relevance of hyperuricemia in pediatric kidney transplant recipients—a CERTAIN registry analysis. Pediatric Transplantation. 26(4). e14265–e14265. 1 indexed citations
4.
Ehren, Rasmus, Marcus R. Benz, Paul Brinkkötter, et al.. (2021). Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy —short version of the updated German best practice guideline (S2e) — AWMF register no. 166-001, 6/2020. Pediatric Nephrology. 36(10). 2971–2985. 18 indexed citations
5.
6.
Ehren, Rasmus, et al.. (2021). The role of the immune system in idiopathic nephrotic syndrome. PubMed. 8(1). 18–18. 21 indexed citations
7.
Erger, Florian, Christine Skerka, Andrea Wenzel, et al.. (2020). Long-term data on two sisters with C3GN due to an identical, homozygous CFH mutation and autoantibodies. Clinical Nephrology. 94(4). 197–206. 1 indexed citations
8.
Weber, Lutz T., Burkhard Tönshoff, Ryszard Grenda, et al.. (2020). Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid‐resistant nephrotic syndrome. Pediatric Transplantation. 25(3). e13955–e13955. 14 indexed citations
9.
Burgmaier, Kathrin, Rasmus Ehren, Angela Kribs, et al.. (2020). Peritoneal dialysis in extremely and very low-birth-weight infants. Peritoneal Dialysis International. 40(2). 233–236. 15 indexed citations
10.
Ehren, Rasmus, et al.. (2020). Therapeutic drug monitoring of mycophenolate mofetil in pediatric patients: novel techniques and current opinion. Expert Opinion on Drug Metabolism & Toxicology. 17(2). 201–213. 15 indexed citations
11.
Benz, Marcus R., Rasmus Ehren, Carsten Müller, et al.. (2019). Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome. Therapeutic Drug Monitoring. 41(6). 696–702. 15 indexed citations
12.
Völker, Linus A., Rasmus Ehren, Franziska Grundmann, et al.. (2019). A newly established clinical registry of minimal change disease and focal and segmental glomerulosclerosis in Germany. Nephrology Dialysis Transplantation. 34(12). 1983–1986. 2 indexed citations
13.
Benz, Marcus R., Rasmus Ehren, Burkhard Tönshoff, & Lutz T. Weber. (2019). Nephrotisches Syndrom im Kindesalter. Monatsschrift Kinderheilkunde. 167(6). 488–499. 1 indexed citations
14.
15.
16.
Habbig, Sandra, et al.. (2018). Discontinuation of maintenance therapy in frequently relapsing nephrotic syndrome. Clinical Nephrology. 91(1). 25–31. 1 indexed citations
17.
Ehren, Rasmus, Michael Kirschfink, Peter F. Zipfel, et al.. (2017). Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS. Pediatric Nephrology. 32(6). 1081–1087. 12 indexed citations
18.
Becker, Jan U., Rasmus Ehren, Sandra Habbig, et al.. (2017). Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schönlein purpura nephritis: the role of early initiation and therapeutic drug monitoring. Pediatric Nephrology. 33(4). 619–629. 19 indexed citations
19.
Ehren, Rasmus, et al.. (2016). Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells. Pediatric Nephrology. 32(8). 1315–1322. 16 indexed citations
20.
Benz, Marcus R., et al.. (2016). Management des steroidsensiblen nephrotischen Syndroms im Kindes- und Jugendalter. Kinder- und Jugendmedizin. 16(5). 359–365.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Nair Breakdown of academic impact, for papers by Pantelitsa Kalliakmani Breakdown of academic impact, for papers by F. Egidi Breakdown of academic impact, for papers by Eric S. Campenot Breakdown of academic impact, for papers by Biswanath Basu Breakdown of academic impact, for papers by John O’Regan Breakdown of academic impact, for papers by Laila‐Yasmin Mani Breakdown of academic impact, for papers by J. Floege Breakdown of academic impact, for papers by Charlotte Colosio Breakdown of academic impact, for papers by Prince Mohan
Rankless by CCL
2026